Search Results

Scale Biosciences announced the availability of ScalePlex an advanced single cell multiplexing technology designed to simplify large-scale single cell genomics studies.

Vizgen, Inc. has announced a partnership with Scale Biosciences (ScaleBio) to combine their single-cell and spatial technologies for enhanced data analysis at the Advances in Genome Biology and Technology (AGBT) 2024 General Meeting in Orlando, Florida.

Scale Biosciences today announced the availability of three new datasets showcasing the performance of its newly released products, including the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell RNA Kit v1.1 with extended throughput, and ScaleBio CRISPR Guide Enrichment Kit, all of which are now shipping.

Scale Biosciences today announced its development of a new two plate workflow to enable dramatic scaling of its technology and a first set of partners to improve ease of use and enable the deployment of their portfolio across new omics applications.

Scale Biosciences, Inc. (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, has transitioned from research and development to commercial stage with the release of its first generation single-cell transcriptomics scRNAseq profiling and analysis solution, establishing new standards for accessible, scalable, and low-cost single-cell sequencing.

Scale Biosciences, Inc. (ScaleBio™), an innovator in single cell sequencing leveraging combinatorial indexing technologies, today announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications.

Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”), a leader in developing eco-friendly antimicrobial compounds, is pleased to announce significant advancements at its state-of-the-art bench scale production

Akoya Biosciences, Inc., The Spatial Biology Company®, announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at the American Association for Cancer Research 2024 Annual Meeting in San Diego, April 5 to 10.

Scale Biosciences today announced a new collaboration with Basepair to provide point and click bioinformatic analysis of single-cell data produced with its patented and disruptive combinatorial indexing technology.

Tome Biosciences, a gene editing startup that launched in late 2023 with $213 million in funding, will eliminate 131 positions in November, according to a Worker Adjustment and Retraining Act notice.